PCOS Has a New Name. Here's What It Means and Why It Matters.
Share
Published May 2026
If you've been searching for information about PCOS lately, you may have seen something surprising: researchers are proposing to rename it entirely.
On May 12, 2026, a landmark paper published in The Lancet proposed that polycystic ovary syndrome (PCOS) be officially renamed polyendocrine metabolic ovarian syndrome, or PMOS. The proposal comes from a global consortium of 56 leading academic, clinical, and patient organizations, and follows over a decade of consultation involving nearly 22,000 doctors, researchers, patient advocates, and women living with the condition.
This isn't a fringe suggestion. It's one of the most coordinated efforts to rename a medical condition in recent history. But it's not finalized. The CDC, WHO, and clinical guidelines haven't updated yet, and most practicing clinicians are still using PCOS. What's happening now is the beginning of a rollout planned across 195 countries over the next three years.
Here's what the proposed PCOS name change is, why researchers say it's necessary, and why it matters for women who have spent years trying to get answers.
Why is PCOS being renamed?
The name PCOS has two problems.
First, it points to the wrong thing. "Polycystic" implies the defining feature is cysts on the ovaries. But not everyone with the condition has ovarian cysts, and many women with completely normal-looking ovaries on ultrasound still have every other symptom. The cysts were never the cause. They were, at best, one possible sign.
Second, it frames a whole-body condition as a gynecological one. That matters clinically. When a condition sounds like a reproductive issue, it gets routed to reproductive specialists. The metabolic side: insulin resistance, elevated androgen levels, cardiovascular risk, thyroid involvement, often goes underaddressed or missed entirely.
Women are sent home with a diagnosis that doesn't fully explain what's happening, and without a treatment plan that addresses the full picture.
What does PMOS stand for?
PMOS stands for polyendocrine metabolic ovarian syndrome. Each word in the new name was chosen deliberately.
Polyendocrine — the condition involves multiple hormonal systems, not just the ovaries. The HPA axis (your stress response system), the HPO axis (which governs the menstrual cycle), insulin signaling, and androgen production are all implicated.
Metabolic — insulin resistance is a central feature for many people with the condition, including those who are not overweight. This connects it to a broader set of long-term health risks: impaired glucose tolerance, gestational diabetes, cardiovascular disease, and dyslipidemia.
Ovarian — the ovaries are still involved. Irregular ovulation, elevated androgens, and menstrual irregularities remain core to the diagnosis. The ovaries aren't removed from the picture; they're just no longer the whole picture.
Together, the proposed name describes this as a multisystem endocrine and metabolic condition that also affects the ovaries, which researchers argue is a far more accurate picture of what's actually happening in the body.
What does the PCOS name change mean for women who've been dismissed?
One of the most consistent experiences women with PCOS describe is not being believed, or being told their symptoms are normal, stress-related, or simply part of being a woman. Irregular cycles. Fatigue. Weight changes that don't respond to diet. Mood instability. Skin changes. Hair loss or excess hair growth.
These symptoms are real and they are connected. But when the name of a condition implies it's mainly about cysts and fertility, it narrows how clinicians think about it, and who gets taken seriously.
The renaming effort was designed in part to address this. A name that signals a complex, long-term, multisystem condition pushes for a full metabolic and endocrine workup, not just a pelvic ultrasound and a referral.
Will my doctor still say PCOS?
Yes, for now. The CDC, WHO, and most clinical guidelines still use PCOS. Insurance codes, electronic health records, and apps haven't changed. Most doctors you see this week will still say PCOS, and that's not a sign they're behind. It's just how institutional medicine moves. Large-scale terminology shifts take years to filter through to everyday clinical practice.
What matters more than the name on your chart is whether your provider is treating the full condition: looking at insulin resistance, cortisol, thyroid function, and metabolic markers alongside reproductive health.
If they're not, it's worth asking.
The science behind PCOS hasn't changed. What's shifting is how the medical community is being asked to think and talk about it. A name that accurately reflects the full condition is harder to dismiss and harder to miss, and for the millions of women who've spent years being told their symptoms were minor or unrelated, that's not a small thing.
The rename isn't official yet. But the conversation it's forcing is already overdue.
Source: Teede HJ, Bahri Khomami M, Morman R, et al. "Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process." The Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00717-8